Novel 3α-diphenylmethoxytropane analogs: Selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 1, 1999, Pages 302-315

  Katz, Jonathan L ^a   Izenwasser, Sari ^a,b   Kline, Richard H ^a   Allen, Andrew C ^a,c   Newman, Amy Hauck ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA DIPHENYLMETHOXYTROPANE DERIVATIVE; 3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; COCAINE DERIVATIVE; DOPAMINE UPTAKE INHIBITOR; MUSCARINIC M1 RECEPTOR; PIRENZEPINE; UNCLASSIFIED DRUG; (1R (EXO,EXO)) 3 (4 FLUOROPHENYL) 8 METHYL 8 AZABICYCLO(3.2.1)OCTANE 2 CARBOXYLIC ACID, METHYL ESTER; (1R-(EXO,EXO))-3-(4-FLUOROPHENYL)-8-METHYL-8- AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLIC ACID, METHYL ESTER; 3 DIPHENYLMETHOXYTROPANE; 3-DIPHENYLMETHOXYTROPANE; COCAINE; DOPAMINE; DRUG DERIVATIVE; TRITIUM; TROPANE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BINDING SITE; COCAINE DEPENDENCE; DISCRIMINATIVE STIMULUS; DOPAMINE RELEASE; DOSE RESPONSE; INHIBITION KINETICS; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DISCRIMINATION LEARNING; DRUG EFFECT; METABOLISM; MOTOR ACTIVITY; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; COCAINE; DISCRIMINATION LEARNING; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MOTOR ACTIVITY; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRITIUM; TROPANES;

EID: 0032589936     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Acri JB, Seidleck BK and Witkin JM (1996) Effects of benztropine on behavioral and toxic effects of cocaine: Comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperizine. J Pharmacol Exp Ther 277:198-206.
2. Bergman J, Madras BK, Johnson SE and Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates, III: Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155.
3. Bowen WD, Hellewell SB and McGarry KA (1989) Evidence for brain sigma receptor. Ear J Pharmacol 163:309-318.
4. Carroll FI, Lewin AH and Kuhar MJ (1997) Dopamine transporter uptake blockers: Structure-activity relationships, in Neurotransmitter Transporters: Structure, Function, and Regulation (Reith MEA ed) pp 263-295, Humana Press, Inc., Totowa, NJ.
5. Church WH, Justice JB Jr. and Byrd LD (1987) Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine. Eur J Pharmacol 139:345-348.
6. Cline EJ, Scheffel U, Boja JW, Carroll FI, Katz JL and Kuhar MJ (1992) Behavioral effects of novel cocaine analogs: A comparison with in vivo receptor binding. J Pharmacol Exp Ther 260:1174-1179.
7. Colpaert FC, Niemegeers CJE and Janssen PAJ (1979) Discriminative stimulus properties of cocaine: Neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol Biochem Behav 10:535-546.
8. Coyle JT and Snyder SH (1969) Antiparkinsonian drugs: Inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science (Wash DC) 166:899-901.
9. deWit H and Wise RA (1977) Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol 31:195-203.
10. Heikkila RE, Cabbat FS, Manzino L and Duvosin RC (1979) Rotational behavior induced by cocaine analogs in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra: Dependence upon dopamine uptake inhibition. J Pharmacol Exp Ther 211:189-194.
11. Izenwasser S, Newman AH, Cox BM and Katz JL (1996) The cocaine-like behavioral effects of meperidine are mediated by activity at the dopamine transporter. Eur J Pharmacol 297:9-17.
12. Izenwasser S, Rosenberger JG and Cox BM (1993) The cocaine analog WIN 35,428 binds to two sites in fresh rat caudate-putamen under the correct assay conditions. Life Sci/Pharm Lett 52: PL141-PL145.
13. Izenwasser S, Terry P, Heller B, Witkin JM and Katz JL (1994) Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors. Eur J Pharmacol 263:277-283.
14. Izenwasser S, Werling LL and Cox BM (1990) Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex. Brain Res 520:303-309.
15. Kline RH, Izenwasser S, Katz JL, Joseph DB, Bowen WD and Newman AH (1997) 3′-Chloro-3α-(diphenylmethoxy)tropane but not 4′-chloro-3α-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile. J Med Chem 40:851-857.
16. Koob G, Vaccarino FJ, Amalric M and Bloom FE (1987) Positive reinforcement properties of drugs: Search for neural substrates, in Brain Reward Systems and Abuse (Engel J and Oreland L eds) pp 35-50, Raven Press, New York.
17. Kuhar MJ, Ritz MC and Boja JW (1991) The dopamine hypothesis of the reinforcing effects of cocaine. Trends Neurosci 14:299-302.
18. 3H]quinuclidinyl benzilate binding to rat brain muscarinic receptors. Mol Pharmacol 26:164-169.
19. 3H]Cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131-141.
20. Malick JB and Barnett A (1975) Central versus peripheral anticholinergic activity as assessed by two in vivo procedures in mice. J Pharm Sci 64:1066-1068.
21. McKearney, JW (1982) Effects of dopamine uptake inhibitors on schedule-controlled behavior in the squirrel monkey. Psychopharmacology 78:377-379.
22. McKeon WB Jr. (1967) In vivo anti-acetylcholine activity in the unanesthetized guinea pig. Arch Int Pharmacodyn Ther 170:461-467.
23. Meltzer PC, Liang AY and Madras BK (1994) The discovery of an unusually selective and novel cocaine analog: difluoropine. Synthesis and inhibition of binding at cocaine recognition sites. J Med Chem 37:2001-2010.
24. Meltzer PC, Liang AY and Madras BK (1996) 2-Carbomethoxy-3-(diarylmethoxy)-1αH,5αH-tropane analogs: Synthesis and inhibition of binding at the dopamine transporter and comparison with piperazines of the GBR series. J Med Chem 39:371-379.
25. Munson PJ and Rodbard D (1980) Ligand: A versatile approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
26. Newman AH, Kline RH, Allen AC, Izenwasser S, George C and Katz JL (1995) Novel 4′- and 4′,4″-substituted-3α-(diphenylmethoxy)tropane analogs are potent and selective dopamine uptake inhibitors. J Med Chem 38:3933-3940.
27. Newman AH, Allen AC, Izenwasser S and Katz JL (1994) Novel 3α-(diphenylmethoxy)tropane analogs: Potent dopamine uptake inhibitors without cocaine-like behavioral profiles. J Med Chem 37:2258-2261.
28. Potter LT, Ferrendelli CA and Hanchett HE (1988) Two affinity states of M1 muscarine receptors. Cell Mol Neurobiol 8:181-191.
29. 1 receptors. Mayo Clin Proc 54:669-674.
30. Ritz MC, Lamb RJ, Goldberg SR and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Wash DC) 237:1219-1223.
31. Roberts DCS, Corcoran ME and Fibiger HC (1977) On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharm Biochem Behav 6:615-620.
32. Rothman RB, Grieg N, Kim A, de Costa BR, Rice KC, Carroll FI and Pert A (1992) Cocaine and GBR 12909 produce equivalent motoric responses at different occupancy of the dopamine transporter. Pharm Biochem Behav 43:1135-1142.
33. Rothman RB (1990) High affinity dopamine reuptake inhibitors as potential cocaine antagonists: A strategy for drug development. Life Sci 46:PL17-PL21.
34. Scheckel C and Boff E (1964) Behavioral effects of interacting imipramine and other drugs with d-amphetamine, cocaine and tetrabenazine. Psychopharmacologia 5:198-206.
35. Scheel-Krüger, J (1972) Behavioural and biochemical comparison of amphetamine derivatives, cocaine, benztropine and tricyclic anti-depressant drugs. Eur J Pharmacol 18:63-73.
36. Snedecor GW and Cochran WG (1967) Statistical Methods, 6th ed., pp. 135-171, Iowa State University Press, Ames, IA.
37. Tolliver BK, Newman AH, Katz JL, Ho LB, Fox LM, Hsu K, Jr and Berger PS (1998) Behavioral and neurochemical effects of dopamine transporter ligands alone and in combination with cocaine: Characterization of 4-chlorobenztropine in vivo. J Pharmacol Exp Ther, in press.
38. Vaugeois JM, Bonnet JJ, Duterte-Boucher D and Constentin J (1993) In vivo occupancy of striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion. Eur J Pharmacol 230:195-201.
39. Witkin JM, Nichols DE, Terry P and Katz JL (1991) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257:706-713.
40. Xu L, Kelkar SV, Lomenzo SA, Izenwasser S, Katz JL, Kline RH and Trudell ML (1997) Synthesis, dopamine transporter affinity, dopamine uptake inhibition and locomotor stimulant activity of 2-substituted-3β-phenyltropane derivatives. J Med Chem 40:858-863.